PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Xenothera, Nantes, France.\', \'Inserm, CRCINA, Université de Nantes, Nantes, France.\', \'CHU Nantes, Université de Nantes, Inserm, Centre de Recherche en Transplantation et Immunologie, Nantes, France.\', \'Avantea, Laboratorio di Tecnologie della Riproduzione, Cremona, Italy.\', \'CER Groupe, Marloie, Belgium.\', \'HKU-Pasteur Research Pole, School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, P.R. China.\', \'Department of Cell Biology and Infection, Institut Pasteur, Paris, France.\', \'Transplantation Immunology Unit, Padua University Hospital, Padova, Italy.\', \'IECM, Immuno-endocrinology, USC1383, Oniris, INRAE, Nantes, France.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1002/eji.202049072
?:hasPublicationType
?:journal
  • European journal of immunology
is ?:pmid of
?:pmid
?:pmid
  • 33576494
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.206
?:rankingScore_hIndex
  • 185
is ?:relation_isRelatedTo_publication of
?:title
  • High neutralizing potency of swine glyco-humanized polyclonal antibodies against SARS-CoV-2.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all